Bladder augmentation and urinary diversion for neurogenic LUTS: current indications
Related Experiment Video
Updated: May 19, 2026

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
Published on: August 9, 2012
Kamran P Sajadi1, Howard B Goldman
1Division of Urology, Oregon Health & Science University, CH10U, 3303 SW Bond Ave, Portland, OR 97239, USA. kpsajadi@gmail.com
Abstract:
Augmentation cystoplasty and urinary diversion are no longer commonplace in the management of patients with neurogenic bladder, but remain an important surgical treatment for those with refractory LUTS who have failed neuromodulation and onabotulinum toxin treatment or who are not candidates for those treatments. Augmentation is an option in patients who can perform intermittent catheterization and is usually performed with ileum or large intestine. Some patients benefit from continent cutaneous catherizable channels. Supravesical urinary diversion may be necessary in more severe cases. Ileovesicostomies are being supplanted by indwelling suprapubic catheters, and when catheters fail conduits may be a better option. When feasible, the diverted bladder should be excised to avoid pyocystis.
Related Concept Videos
Imaging Studies VI: Voiding Cystourethrography and Cystography
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Urinary Tract Calculi VI: Surgical Management
Nursing Assessment of the Genitourinary System II: Inspection and Palpation